Title:
FUSED IMIDE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2023/088406
Kind Code:
A1
Abstract:
Provided are a fused imide derivative as shown in formula I, a preparation method therefor, a pharmaceutical composition containing same, and the use thereof in the treatment of relevant diseases (such as cancers).
Inventors:
ZHANG YINSHENG (CN)
REN JING (CN)
WANG JINAN (CN)
XU SHENG (CN)
YANG XIAOJUN (CN)
DENG LI (CN)
HUANG YONGKANG (CN)
WANG QINGLIN (CN)
REN JING (CN)
WANG JINAN (CN)
XU SHENG (CN)
YANG XIAOJUN (CN)
DENG LI (CN)
HUANG YONGKANG (CN)
WANG QINGLIN (CN)
Application Number:
PCT/CN2022/132769
Publication Date:
May 25, 2023
Filing Date:
November 18, 2022
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61K31/343; C07D498/04; A61K31/423; A61K31/4523; A61K31/4525; A61P35/00; A61P37/00; C07D491/04; C07D498/00
Domestic Patent References:
| WO2021185291A1 | 2021-09-23 | |||
| WO2020048547A1 | 2020-03-12 | |||
| WO2020048546A1 | 2020-03-12 | |||
| WO2020048548A1 | 2020-03-12 | |||
| WO2021113557A1 | 2021-06-10 | |||
| WO2021018018A1 | 2021-02-04 |
Foreign References:
| CN113412259A | 2021-09-17 |
Attorney, Agent or Firm:
BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD. (CN)
Download PDF: